600511 国药股份
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)9.14814.31114.55114.48212.581
总资产报酬率 ROA (%)4.4366.9166.8176.6305.632
投入资产回报率 ROIC (%)7.28011.29411.48711.62110.153

边际利润分析
销售毛利率 (%)7.0188.0318.4017.8147.783
营业利润率 (%)5.2315.9255.9235.2674.738
息税前利润/营业总收入 (%)4.9765.6445.8445.2224.732
净利润/营业总收入 (%)4.1414.6974.6794.1503.738

收益指标分析
经营活动净收益/利润总额(%)87.36685.36584.82886.60582.840
价值变动净收益/利润总额(%)16.09612.61610.84911.59011.505
营业外收支净额/利润总额(%)-1.192-0.460-0.262-0.1010.215

偿债能力分析
流动比率 (X)2.0372.0352.0221.9301.968
速动比率 (X)1.6771.7501.7311.6541.696
资产负债率 (%)46.24845.97446.43748.74947.424
带息债务/全部投入资本 (%)14.60315.01216.49814.20815.513
股东权益/带息债务 (%)543.504531.600472.573563.460518.621
股东权益/负债合计 (%)104.588105.737103.38493.59596.890
利息保障倍数 (X)-25.685-22.238-92.200-132.292-280.550

营运能力分析
应收账款周转天数 (天)67.81753.26045.32643.22672.981
存货周转天数 (天)35.19730.24231.23727.58430.967